skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
Early Outlook Report 2022

Download Q2 2022 Outlook Report Whitepaper

The full report covers catalysts expected to occur in Q2 2022 for drugs, devices, diagnostics and deals, along with expected large-impact, potentially market moving catalysts through Q1 2022. Plus results of large impact catalysts highlighted in the Q1 2022 outlook report, including the outcome of Likelihood of Approval analysis (LOA).
q2 outlook report cover

Download Q2 2022 Outlook Report Infographics

Your look at the outcomes for 2 catalysts covered in the Q1 Outlook Report from Informa Pharma Intelligence. Your free infographic includes:

  • The catalysts tracked and the drugs impacted
  • Catalyst results, including corresponding stock valuations for the period following the event
  • Exclusive analysis, including % change of Biomedtracker’s exclusive likelihood of approval (LOA) outlook for the drugs – the biggest indicator of a drug’s future success
bmt catalyst

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: